Bahl & Gaynor Inc. Has $2.40 Million Stake in Genpact Limited (NYSE:G)

Bahl & Gaynor Inc. trimmed its stake in shares of Genpact Limited (NYSE:G) by 33.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 72,942 shares of the business services provider’s stock after selling 37,177 shares during the period. Bahl & Gaynor Inc.’s holdings in Genpact were worth $2,403,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. EdgeRock Capital LLC acquired a new position in shares of Genpact in the fourth quarter valued at approximately $25,000. EverSource Wealth Advisors LLC boosted its holdings in Genpact by 106.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 914 shares of the business services provider’s stock worth $32,000 after purchasing an additional 471 shares during the last quarter. GAMMA Investing LLC acquired a new position in Genpact during the fourth quarter worth $43,000. Massmutual Trust Co. FSB ADV boosted its holdings in Genpact by 120.0% during the first quarter. Massmutual Trust Co. FSB ADV now owns 1,813 shares of the business services provider’s stock worth $60,000 after purchasing an additional 989 shares during the last quarter. Finally, Parallel Advisors LLC boosted its holdings in Genpact by 22.6% during the fourth quarter. Parallel Advisors LLC now owns 1,882 shares of the business services provider’s stock worth $65,000 after purchasing an additional 347 shares during the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Genpact

In other Genpact news, Director N. V. Tyagarajan sold 1,000 shares of the firm’s stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $33.17, for a total value of $33,170.00. Following the transaction, the director now directly owns 7,300 shares of the company’s stock, valued at approximately $242,141. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 2.80% of the company’s stock.

Genpact Stock Performance

NYSE:G traded up $0.09 during mid-day trading on Tuesday, reaching $33.60. 405,956 shares of the company’s stock were exchanged, compared to its average volume of 1,443,435. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.54 and a current ratio of 1.54. Genpact Limited has a one year low of $29.41 and a one year high of $39.44. The firm has a market capitalization of $6.05 billion, a PE ratio of 9.53, a price-to-earnings-growth ratio of 1.56 and a beta of 1.11. The business’s fifty day simple moving average is $32.65 and its two-hundred day simple moving average is $33.34.

Genpact (NYSE:G) last released its earnings results on Thursday, May 9th. The business services provider reported $0.68 EPS for the quarter, beating the consensus estimate of $0.62 by $0.06. Genpact had a net margin of 14.21% and a return on equity of 22.71%. The firm had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.11 billion. Analysts anticipate that Genpact Limited will post 2.7 earnings per share for the current fiscal year.

Genpact Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Wednesday, September 11th will be issued a $0.1525 dividend. This represents a $0.61 annualized dividend and a yield of 1.82%. The ex-dividend date is Wednesday, September 11th. Genpact’s dividend payout ratio is currently 17.43%.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. BMO Capital Markets cut their price target on shares of Genpact from $39.00 to $38.00 and set a “market perform” rating for the company in a research note on Friday, May 10th. Citigroup dropped their price objective on shares of Genpact from $36.00 to $33.00 and set a “neutral” rating on the stock in a research report on Monday, April 22nd. Needham & Company LLC reissued a “buy” rating and issued a $40.00 price objective on shares of Genpact in a research report on Friday, May 10th. JPMorgan Chase & Co. raised shares of Genpact from an “underweight” rating to a “neutral” rating and dropped their price objective for the company from $43.00 to $40.00 in a research report on Wednesday, July 17th. Finally, Wedbush reissued a “neutral” rating and issued a $35.00 price objective on shares of Genpact in a research report on Friday, May 10th. Six research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $37.63.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.